Cargando…
How Do We Interpret the Presence of Donor-Specific Antibodies When There Is No Rejection?
Autores principales: | Crew, R. John, Fajardo, Melissa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698305/ https://www.ncbi.nlm.nih.gov/pubmed/31440694 http://dx.doi.org/10.1016/j.ekir.2019.05.008 |
Ejemplares similares
-
Imagining a Better Outcome for Chronic Antibody-Mediated Rejection—Will Blocking Interleukin-6 Signaling Help?
por: Muthukumar, Thangamani, et al.
Publicado: (2022) -
How do we know when patients sleep properly or why they do not?
por: Sjöberg, Folke, et al.
Publicado: (2013) -
How can we improve the interpretation of systematic reviews?
por: Tricco, Andrea C, et al.
Publicado: (2011) -
Goal-directed or goal-misdirected - how should we interpret the literature?
por: Roche, Anthony M, et al.
Publicado: (2010) -
Glucocorticoids: do we know how they work?
por: Saklatvala, Jeremy
Publicado: (2002)